Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts

Maxime R F Gosselin1, Virginie Mournetas2, Malgorzata Borczyk3

  • 1School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom.

Elife
|September 27, 2022
PubMed

Insights

Duchenne muscular dystrophy (DMD) causes muscle degeneration by affecting myoblasts, the cells responsible for muscle growth and repair. These dystrophin-deficient cells exhibit abnormal gene expression and function, revealing them as a new therapeutic target.

Area of Science:

  • Muscle Biology
  • Cellular and Molecular Medicine
  • Regenerative Medicine

Background:

  • Duchenne muscular dystrophy (DMD) is characterized by progressive muscle degeneration and impaired repair.
  • The role of dystrophin-deficient myoblasts in DMD pathogenesis was previously unclear.
  • Myoblasts are crucial for muscle growth and regeneration.

Purpose of the Study:

  • To investigate whether dystrophic myoblasts exhibit abnormalities.
  • To identify molecular and functional defects in primary mouse and human DMD myoblasts.
  • To explore myoblasts as a potential therapeutic target for DMD.

Main Methods:

  • Transcriptomic analysis of dystrophic myoblasts.
  • Genome-scale metabolic modeling.
  • Functional assays including proliferation, chemotaxis, and differentiation.
  • Cross-species comparison of mouse and human DMD myoblasts.

Main Results:

  • Dystrophic myoblasts showed significant alterations in gene expression, including downregulation of MyoD-controlled genes essential for muscle development.
  • Functional deficits included increased proliferation, reduced chemotaxis, and accelerated differentiation.
  • Metabolic analysis revealed dysregulation in glycolysis, leukotriene metabolism, and fatty acid oxidation.
  • Abnormalities were confirmed in both mouse and human DMD myoblasts, indicating cell-autonomous defects.

Conclusions:

  • Duchenne muscular dystrophy affects myoblasts, leading to impaired muscle regeneration.
  • These cell-autonomous defects in myoblasts contribute to the disease progression.
  • Dystrophic myoblasts represent a novel therapeutic target for DMD treatment.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K